Allergan, Inc. v. Watson Laboratories, Inc.
568 U.S. 970, 133 S. Ct. 497, 184 L. Ed. 2d 311, 81 U.S.L.W. 329, 2012 WL 4855250, 2012 U.S. LEXIS 8228
This text of 568 U.S. 970 (Allergan, Inc. v. Watson Laboratories, Inc.) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
Allergan, Inc. v. Watson Laboratories, Inc., 568 U.S. 970, 133 S. Ct. 497, 184 L. Ed. 2d 311, 81 U.S.L.W. 329, 2012 WL 4855250, 2012 U.S. LEXIS 8228 (2012).
Opinion
C. A. Fed. Cir. Certiorari denied.
Free access — add to your briefcase to read the full text and ask questions with AI
Cite This Page — Counsel Stack
Bluebook (online)
568 U.S. 970, 133 S. Ct. 497, 184 L. Ed. 2d 311, 81 U.S.L.W. 329, 2012 WL 4855250, 2012 U.S. LEXIS 8228, Counsel Stack Legal Research, https://law.counselstack.com/opinion/allergan-inc-v-watson-laboratories-inc-scotus-2012.